Immediate Impact
3 from Science/Nature 59 standout
Citing Papers
Theranostic Fluorescent Probes
2024 Standout
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Works of M. Lind being referenced
O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC
2003
The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M. Lind | 240 | 90 | 52 | 141 | 94 | 20 | 478 | |
| Merry Tetef | 255 | 112 | 19 | 81 | 146 | 28 | 559 | |
| Fulvio Brema | 381 | 65 | 31 | 86 | 78 | 36 | 553 | |
| John W. McBroom | 130 | 73 | 94 | 143 | 103 | 18 | 534 | |
| Matthew Vaughan | 158 | 184 | 46 | 124 | 184 | 17 | 548 | |
| Phb Willemse | 298 | 60 | 61 | 71 | 100 | 33 | 510 | |
| M. Berman | 168 | 132 | 90 | 61 | 79 | 19 | 570 | |
| E. Crucitta | 191 | 81 | 30 | 131 | 123 | 22 | 520 | |
| V. Barbounis | 224 | 112 | 59 | 38 | 101 | 31 | 465 | |
| Barbara Rogers | 128 | 139 | 13 | 110 | 98 | 28 | 426 | |
| J. P. Eder | 145 | 79 | 8 | 112 | 140 | 20 | 412 |
All Works
Loading papers...